Censa Pharmaceuticals Overview
- Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$544M
Censa Pharmaceuticals General Information
Description
Developer of bio-medical therapeutics designed to treat (ultra) orphan CNS disorders. The company's therapeutics treat orphan metabolic diseases with earlier stage programs targeting central nervous system diseases, disorders of neurotransmitter degradation and synthesis, enabling patients to recover debilitating diseases.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Pharmaceuticals
Acquirer
Primary Office
- 65 William Street
- Suite 200
- Wellesley, MA 02481
- United States
Censa Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 29-May-2020 | $544M | 00.000 | 00000 | Completed | Clinical Trials - Phase 3 |
| 3. Merger/Acquisition | 05-Jan-2018 | 0000 | 0000 | Cancelled | Startup | |
| 2. Early Stage VC | 21-Nov-2017 | $1.5M | $3.01M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 19-Apr-2016 | $1.51M | $1.51M | 000.00 | Completed | Startup |
Censa Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 0.000 |
Censa Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of bio-medical therapeutics designed to treat (ultra) orphan CNS disorders. The company's therapeutics treat o
Biotechnology
Wellesley, MA
7
As of 2018
00.000
0000
0000-00-00
000000&0
00.000
000000
ing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
0000 000000000
Cambridge, MA
00
As of 0000
00000
00000000000
00000
000000
rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat c
0000000000000
Bedford, MA
000
As of 0000
00000
0000
0000-00-00
000000000
00000
Add Comparison
Censa Pharmaceuticals Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Synlogic | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
| 00000000 000000000 | Formerly VC-backed | Bedford, MA | 000 | 00000 | 000000000 | 00000 |
| 00000000 000000000 | Formerly PE-Backed | San Rafael, CA | 0000 | 00000 | 0000 | 00000 |
Censa Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Censa Pharmaceuticals Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Arkin Holdings | Venture Capital | Minority | 000 0000 | 000000 0 | |
| InClin | Angel Group | Minority | 000 0000 | 000000 0 |